74.66

1.63% 1.13

Haemonetics Corp (HAE)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Haemonetics Corp stock is traded at $74.66, with a volume of 246.86K. It is up +1.63% in the last 24 hours and down -4.06% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Previous Close:

$73.53

Open:

$73.22

24h Volume:

246.86K

Relative Volume:

0.42

Market Cap:

$3.80B

Revenue:

$1.27B

Net Income/Loss:

$126.57M

P/E Ratio:

29.98

EPS:

2.49

Net Cash Flow:

$128.75M

1W Performance:

+2.23%

1M Performance:

-4.06%

6M Performance:

-20.84%

1Y Performance:

-15.49%

1-Day Range:

$73.22

$74.90

1-Week Range:

$70.25

$74.90

52-Week Range:

$70.25

$97.97

Haemonetics Corp Stock (HAE) Company Profile

Name

Haemonetics Corp

Sector

Healthcare (1181)

Industry

Medical Instruments & Supplies (58)

Phone

(781) 848-7100

Address

125 SUMMER STREET, BOSTON, MA

Employee

3,657

Twitter

@HaemoneticsCorp

Next Earnings Date

2024-11-07

Latest SEC Filings

HAE's Discussions on Twitter

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-13-22	Initiated	Mizuho	Buy
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral
Aug-17-21	Resumed	Raymond James	Outperform
Jun-17-21	Initiated	Citigroup	Buy
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy
Aug-07-19	Reiterated	Barrington Research	Outperform
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform
May-08-19	Reiterated	Barrington Research	Outperform
Aug-09-18	Reiterated	Barrington Research	Outperform
Feb-07-18	Reiterated	Barrington Research	Outperform
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-08-17	Reiterated	Barrington Research	Outperform
Aug-08-17	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-13-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Feb-07-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-08-16	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-07-16	Reiterated	The Benchmark Company	Hold
Sep-20-16	Downgrade	CJS Securities	Market Outperform → Market Perform
Aug-15-16	Downgrade	Sidoti	Buy → Neutral
Aug-02-16	Reiterated	Jefferies	Buy
Aug-02-16	Reiterated	The Benchmark Company	Hold

View All

Haemonetics Corp Stock (HAE) Latest News

Nov 04, 2024

Harbor Capital Advisors Inc. Acquires 30,389 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat

Nov 04, 2024

Nov 03, 2024

F M Investments LLC Purchases New Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat

Nov 03, 2024

Nov 02, 2024

Assenagon Asset Management S.A. Cuts Stock Position in Haemonetics Co. (NYSE:HAE) - MarketBeat

Nov 02, 2024

Nov 01, 2024

Haemonetics Co. (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 01, 2024

Oct 31, 2024

Haemonetics stock hits 52-week low at $70.5 amid challenges - Investing.com

Oct 31, 2024

Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Oct 31, 2024

Haemonetics (HAE) Set to Announce Quarterly Earnings on Thursday - Defense World

Oct 31, 2024

Oct 26, 2024

Boston Trust Walden Corp Increases Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat

Oct 26, 2024

Oct 24, 2024

Riverwater Partners LLC Acquires 29,109 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat

Oct 24, 2024

Oct 17, 2024

Creative Planning Makes New Investment in Haemonetics Co. (NYSE:HAE) - Defense World

Oct 17, 2024

Oct 14, 2024

Potential Price Increase for Haemonetics Corp. (HAE) After Recent Insider Activity - Knox Daily

Oct 14, 2024

Oct 13, 2024

Northwestern Mutual Wealth Management Co. Sells 161 Shares of Haemonetics Co. (NYSE:HAE) - Defense World

Oct 13, 2024

Oct 11, 2024

Are Haemonetics Corp. (HAE) shares a good deal now? - US Post News

Oct 11, 2024

Balance Sheet Dive: Haemonetics Corp. (HAE)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 11, 2024

Blood Collection Devices Global Market 2024, with Profiles of Abbott, Becton, Dickinson, FL Medical, Fresenius, Greiner Bio-One, Haemonetics, Medtronic, Nipro Medical, Qiagen, Sarstedt & Terumo BCT - Yahoo Finance

Oct 11, 2024

Oct 09, 2024